<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    INMODE LTD.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About INMODE LTD.

    InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $447,000,000
    • SIC CODE
      3845
    • NIN CODE
      ####
    • LEADERSHIP
      Moshe Mizrahy
    • FOUNDED
      2008
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Strongbridge Biopharma plc

    Strongbridge Biopharma plc

    Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focu...

    Strongbridge Biopharma is a global commercial-s...

    Filing Type:    PU
    Spark Therapeutics, Inc.

    Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitabi...

    Spark Therapeutics, a fully integrated company,...

    Filing Type:    PU
    Axcella Health Inc.

    Axcella Health Inc.

    Axcella is designing and developing AXA Candidates, compositions of endogenous met...

    Axcella is designing and developing AXA Candida...

    Filing Type:    PU
    Aoxing Pharmaceutical Company, Inc.

    Aoxing Pharmaceutical Company, Inc.

    Aoxing Pharmaceutical Company Inc., is a specialty pharmaceutical company. The Com...

    Aoxing Pharmaceutical Company Inc., is a specia...

    Amount Raised:    $5,000,000
    Fundraising Status:    VT
    Filing Type:    PU
    Akers Biosciences Inc.

    Akers Biosciences Inc.

    Akers Biosciences, Inc. (aka Akers Bio) was founded in 1989, with the objective of...

    Akers Biosciences, Inc. (aka Akers Bio) was fou...

    Filing Type:    PU
    Helius Medical Technologies, Inc.

    Helius Medical Technologies, Inc.

    Helius Medical Technologies, Inc. (Helius) is a neurotech company in the medical d...

    Helius Medical Technologies, Inc. (Helius) is a...

    Filing Type:    PU
    Sonova Holding AG

    Sonova Holding AG

    Sonova, headquartered in Stäfa, Switzerland, is a leading provider of innovative h...

    Sonova, headquartered in Stäfa, Switzerland, is...

    Filing Type:    PU
    Inogen, Inc

    Inogen, Inc

    Inogen’s mission to improve the quality of life of supplemental oxygen users beg...

    Inogen’s mission to improve the quality of li...

    Filing Type:    PU
    Ekso Bionics Holdings, Inc.

    Ekso Bionics Holdings, Inc.

    Ekso BionicsÂŽ is a pioneer in the field of robotics. For over a decade we have be...

    Ekso BionicsÂŽ is a pioneer in the field of rob...

    Filing Type:    PU
    Titan Medical Inc.

    Titan Medical Inc.

    Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario...

    Titan Medical Inc. is a Canadian public company...

    Filing Type:    PU
    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc.

    Virtuoso Surgical, Inc. was born out of a collaborative research effort developing...

    Virtuoso Surgical, Inc. was born out of a colla...

    Filing Type:    RA
    Medigus Ltd.

    Medigus Ltd.

    Medigus is a medical device company specializing in developing minimally invasive ...

    Medigus is a medical device company specializin...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.